FDA rejects weight-loss drug
Links shared publicly online about this topic.
- 780total visits
FDA rejects weight-loss drug
View full resource at health.yahoo.net
Tags: Obesity, Cancer, Drug, Pharma, Healthy Living, FDA
Most Recently Shared on October 23, 2010 at 10:40 pm By:
FDA rejects weight-loss drug http://bit.ly/c03Ugg
Weight loss pill Qnexa wins panel vote and awaits approval
news-medical.net — “The drug was rejected in a 10-6 vote the first time it came before a Food and Drug Administration (FDA) advisory panel, in 2010, due to safety concerns. However when the medication returned for another review in February, the advisory committee gave it near-unanimous approval (20-2). Because the FDA often follows the advisory panel's advice, Qnexa is likely to get FDA approval, probably by mid-April.” View full resource at news-medical.net
Most Recently Shared on April 5, 2012 at 11:08 pm By:
Diet News: Weight loss pill Qnexa wins panel vote and awaits approval: The drug was rejected in a 10-6 vote the ... http://t.co/rGbONdEq
New diet drug Qnexa awaits FDA approval amid safety questions – USATODAY.com
usatoday.com — “Some experts say it could potentially help dieters lose about 10% of their weight, but with its former FDA rejection, how safe is it?” View full resource at usatoday.com
Most Recently Shared on April 4, 2012 at 11:02 pm By:
Diet drug Qnexa awaits FDA approval amid safety questions http://t.co/aMYJ6Ol8
New diet drug Qnexa awaits FDA approval amid safety questions – USATODAY.com
usatoday.com — “Some experts say it could potentially help dieters lose about 10% of their weight, but with its former FDA rejection, how safe is it?” View full resource at usatoday.com
Most Recently Shared on April 4, 2012 at 10:45 pm By:
Diet drug Qnexa awaits FDA approval amid safety questions http://t.co/YjlUT7Bn
FDA rejects call to ban BPA from food packaging - BusinessWeek
businessweek.com — “The Food and Drug Administration has rejected a petition from environmentalists that would have banned the plastic-hardening chemical bisphenol-A from all food and drink packaging, including plastic bottles and canned food.” View full resource at businessweek.com
Most Recently Shared on March 30, 2012 at 9:59 pm By:
Ari Brown Doctor, Pediatrician, and Physician
FDA says they won't ban BPA from food packaging. There is not enough evidence of adverse health effects. Research... http://t.co/t4sYJ8La
FDA panel backs Glaxo drug for rare cancer | ajc.com
ajc.com — “WASHINGTON — A panel of cancer experts rejected an experimental Merck drug for a rare form of cancer on Tuesday while recommending approval of a GlaxoSmithKline treatment for the same disease.” View full resource at ajc.com
Most Recently Shared on March 21, 2012 at 4:29 pm By:
Tom Heston, MD Family Medicine Doctor, Physician, and Doctor
FDA panel backs Glaxo drug for rare cancer - Atlanta Journal Constitution http://t.co/p4jwFZcO #medicine
FDA Backs Glaxo Drug For Rare Cancer | ThirdAge
thirdage.com — “ A panel of cancer experts rejected an experimental Merck drug for a rare form of cancer on Tuesday while recommending approval of a GlaxoSmithKline treatment for the same disease. Neither drug appears to help patients live longer, but panelists said Glaxo's Votrient helped delay tumor growth in the most vulnerable patients.” View full resource at thirdage.com
Most Recently Shared on March 21, 2012 at 12:19 am By:
FDA Backs Glaxo Drug For Rare Cancer http://t.co/QMfj2u64
FDA Panel Rejects Proposed Merck Cancer Drug For Sarcoma Patients
nasdaq.com — “NASDAQ News: FDA Panel Rejects Proposed Merck Cancer Drug For Sarcoma Patients” View full resource at nasdaq.com
Most Recently Shared on March 20, 2012 at 9:46 pm By:
FDA Panel Rejects Proposed Merck Cancer Drug For Sarcoma Patients: FDA Panel Rejects Proposed Merck Cancer Drug ... http://t.co/ZTW7ZLZe
FDA panel backs Glaxo drug for rare sarcoma cancer - Yahoo! News
news.yahoo.com — “From Yahoo! News: A panel of cancer experts rejected an experimental Merck drug for a rare form of cancer on Tuesday while recommending approval of a GlaxoSmithKline treatment for the same disease. Neither drug appears to help patients live longer, but panelists said Glaxo's Votrient helped delay tumor growth in the most vulnerable patients.” View full resource at news.yahoo.com
Most Recently Shared on March 20, 2012 at 6:57 pm By:
FDA panel backs Glaxo drug for rare sarcoma cancer: A panel of cancer experts voted against an experimental Merc... http://t.co/CS4hfxkn
FDA Panel Rejects Merck Drug for Sarcoma, but Backs Glaxo's Votrient - WSJ.com
online.wsj.com — “A federal advisory panel rejected an experimental Merck & Co. drug for use in patients with soft-tissue or bone sarcomas—on concerns that it didn't work well enough to offset potentially serious side effects—while backing a different drug from GlaxoSmithKline.” View full resource at online.wsj.com
Most Recently Shared on March 20, 2012 at 5:37 pm By:
FDA Panel Backs Glaxo Drug for Sarcoma http://t.co/Cc9B6D9P
FDA panel backs Glaxo drug for rare sarcoma cancer - Yahoo! News
news.yahoo.com — “From Yahoo! News: A panel of cancer experts rejected an experimental Merck drug for a rare form of cancer on Tuesday while recommending approval of a GlaxoSmithKline treatment for the same disease. Neither drug appears to help patients live longer, but panelists said Glaxo's Votrient helped delay tumor growth in the most vulnerable patients.” View full resource at news.yahoo.com
Most Recently Shared on March 20, 2012 at 5:29 pm By:
HealthTrendster Health Executive
FDA panel backs Glaxo drug for rare sarcoma cancer - A panel of cancer experts has backed the benefits of a GlaxoSmi... http://t.co/k7JJ13Oc
Can Qnexa Help You Lose Weight? | Weight-Loss Drug Qnexa & Side Effects | Maintain Weight Loss | MyHealthNewsDaily.com
myhealthnewsdaily.com — “The weight loss drug qnexa may soon win FDA approval. But can the drug really help you lose weight?” View full resource at myhealthnewsdaily.com
Most Recently Shared on March 3, 2012 at 2:31 pm By:
David L. Katz, MD, MPH Internist, CAM, Integrative Physician, Physician, and Doctor
reflecting on Qnexa - http://t.co/MKmqvkdn
New Diet Drug Qnexa Promises 10% Weight Loss - At What Price? - Forbes
forbes.com — “Qnexa could be the next hit diet drug, helping people lose up to 10 percent of their body weight. But even if approved by the FDA, is it really safe, or could it cause heart damage like Phen-Fen before it?” View full resource at forbes.com
Most Recently Shared on February 24, 2012 at 12:04 am By:
Melanie Haiken, Health Writer Health Advocate
New Diet Drug Qnexa Promises 10% Weight Loss - At What Price? - Forbes http://t.co/38wDC438
U.S. advisers back experimental obesity pill
health.yahoo.net — “SILVER SPRING, Maryland (Reuters) - Experimental obesity drug Qnexa won the backing of U.S. health advisors on Wednesday, raising hopes for approval of the first prescription weight-loss pill in 13 years. Vivus Inc's Qnexa was one of three promising obesity drugs rejected by the U.S.” View full resource at health.yahoo.net
Most Recently Shared on February 23, 2012 at 6:37 pm By:
Amy Rezak Doctor, Surgeon, and Physician
U.S. advisers back experimental obesity pill http://t.co/n44ZUW1w
UCLA Professor Says Qnexa Has The "Highest Efficacy" for Weight Loss
emaxhealth.com — “After a second review of its effectiveness and safety profile, Qnexa, an anti-obesity drug by Vivus Inc, has gained an FDA panel's approval and may so...” View full resource at emaxhealth.com
Most Recently Shared on February 23, 2012 at 5:05 pm By:
Denise Reynolds RD Nutritionist and Dietitian
UCLA Professor on FDA Panel Says Qnexa Has The "Highest Efficacy" for Weight Loss http://t.co/tCgqYnQr
U.S. advisers back experimental obesity pill | Reuters
reuters.com — “SILVER SPRING, Maryland (Reuters) - Experimental obesity drug Qnexa won the backing of U.S. health advisors on Wednesday, raising hopes for approval of the first prescription weight-loss pill in 13 years.Vivus” View full resource at reuters.com
Most Recently Shared on February 23, 2012 at 7:23 am By:
Ben Hirschler Health Communicator
First new #obesity pill in 13 years comes closer. #Vivus stock nearly doubles after hours on panel vote for #Qnexa http://t.co/1qzes7rx
Advertisement
